BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2650253)

  • 1. Successful renal allografts in recipients with a positive standard, DTE negative cross-match.
    Barger BO; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):746-7. PubMed ID: 2650253
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful renal allografts in recipients with crossmatch-positive, dithioerythritol-treated negative sera. Race, transplant history, and HLA-DR1 phenotype.
    Barger B; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplantation; 1989 Feb; 47(2):240-5. PubMed ID: 2645705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody.
    Louis P; Senitzer D; Tellis VA; Matas AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):764-5. PubMed ID: 2650262
    [No Abstract]   [Full Text] [Related]  

  • 6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):400-2. PubMed ID: 1990565
    [No Abstract]   [Full Text] [Related]  

  • 8. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 9. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful renal transplantation in the presence of donor specific HLA IgM antibodies.
    Tardif GN; McCalmon RT
    Transplant Proc; 1995 Feb; 27(1):664-5. PubMed ID: 7879136
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation.
    Albrechtsen D; Flatmark A; Halvorsen S; Jervell J; Solheim BG; Thorsby E
    Scand J Urol Nephrol Suppl; 1980; 54():25-8. PubMed ID: 7013036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of pre- and postgraft antibodies against endothelial cells (umbilical cord) in kidney allografts.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1981 Sep; 13(3):1551-5. PubMed ID: 7029813
    [No Abstract]   [Full Text] [Related]  

  • 14. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
    Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do HLA-nonidentical renal allografts survive 10 years or more?
    Thomas J; Thomas F; Lee HM
    Transplant Proc; 1977 Mar; 9(1):85-9. PubMed ID: 141140
    [No Abstract]   [Full Text] [Related]  

  • 16. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new strategy to improve kidney graft survival: the induction of CML nonresponsiveness.
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Gabb BW
    Transplant Proc; 1979 Mar; 11(1):736-42. PubMed ID: 88102
    [No Abstract]   [Full Text] [Related]  

  • 18. Bw4/Bw6 matching and renal allograft survival in homozygous recipients.
    Spreng WM; Nathan P; First MR
    Proc Clin Dial Transplant Forum; 1979; 9():93-4. PubMed ID: 399520
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-HLA immunological factors in eighteen HLA-identical renal allografts.
    Dossetor JB; Kovithavongs T
    Proc Eur Dial Transplant Assoc; 1983; 19():438-44. PubMed ID: 6224209
    [No Abstract]   [Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.